|
|
加大旧金山分校研究“AeroNabs”鼻喷雾剂可能有助于减缓COVID-19的传播！
(NBC)University of California San Francisco researchers believe a nasal spray could be one of the keys to dramatically slowing down the spread of the coronavirus.
加州大学旧金山分校的研究人员认为，鼻喷剂可能是显著减缓冠状病毒传播的关键之一。
"Through some feats of biological engineering, we generated a very potent molecule that bands very tightly," UCSF graduate student Michael Schoof said. "So it will do the job that a traditional antibody would do."
“通过一些生物工程的壮举，我们产生了一个非常强大的分子，它紧密地结合在一起，”加州大学旧金山分校的研究生Michael Schoof说。“所以它能做传统抗体能做的工作。”
COVID-19 uses so-called "spike proteins" to infect cells in lungs, which then create more virus cells that then infect more lung cells, according to a virus explainer video from UCSF. .
根据加州大学旧金山分校的一段病毒解释视频，COVID-19使用所谓的“刺突蛋白”感染肺部细胞，然后产生更多病毒细胞，然后感染更多肺部细胞。
Schoof led a team of researchers who found that certain nanobodies, which in this case came from camels and llamas, can bind to those coronavirus proteins and prevent them from latching on to lung cells and multiplying.
Schoof领导的一个研究小组发现，某些来自骆驼和大羊驼的纳米体可以与冠状病毒蛋白结合，阻止它们附着在肺细胞上并繁殖。
The team's research led to the engineering of a more potent version of the nanobodies, which resulted in the creation of synthetic antibodies known as "AeroNabs."
该小组的研究导致了更有效的纳米体的工程，这导致了合成抗体的产生，称为“AeroNabs”。
The goal is to make AeroNabs an inexpensive, over-the-counter medication with the potential to be available in months. But Schoof said we are still dealing with science and it is important to not set a hard timeline for its availability.
该公司的目标是研制出一种便宜的非处方药物，有望在几个月内上市。但Schoof表示，我们仍在进行科学研究，重要的是不要为其可用性设定硬性时间表。
联系人:-
电话号码: |
|
发表于 2020-8-13 14:19:56
发表于 2022-12-30 09:54:11